Open AccessSafety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected
Author(s) -
Crowell Cs,
Williams Pl,
Cenk Yildirim,
Van Dyke Rb,
Renee Smith,
Chadwick Eg,
Seage Gr,
Alexandria DiPerna,
Rohan Hazra
Publication year - 2020
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002550
Subject(s) - medicine , efavirenz , relative risk , didanosine , in utero , pediatrics , pregnancy , prospective cohort study , cohort study , confounding , obstetrics , confidence interval , sida , viral load , human immunodeficiency virus (hiv) , immunology , fetus , viral disease , antiretroviral therapy , biology , genetics
To evaluate whether there is an increased risk of neurologic diagnoses in children who are HIV-exposed but uninfected (CHEU) exposed in utero to specific antiretroviral medications.